Scangos George A
- SEC CIK
- 0001202102
No open-market purchases or sales filed in the past year.
Current role at each company
- VYGR Voyager Therapeutics, Inc.Directoras of Jun 11, 2026
- A Agilent Technologies, Inc.Directoras of Mar 23, 2026
- VIR Vir Biotechnology, Inc.Directoras of Feb 25, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Scangos George A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VIR Vir Biotechnology, Inc.
Director7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2025 (view filing) | Feb 24 | 1 day | Scangos George ADirector | SSale | −10.1K | $9.45 | −$95.0K | −1.4%698.2K after | 10b5-1 |
| Feb 19, 2025 (view filing) | Feb 18 | 1 day | Scangos George ADirector | SSale | −11.0K | $9.81 | −$107.6K | −1.5%708.3K after | 10b5-1 |
| Feb 26, 2024 (view filing) | Feb 22-26 | 4 days | Scangos George ADirector | SSale | −27.8K | $11.07 | −$307.2K | −19.7%113.0K after | 2 lots10b5-1 |
| Feb 20, 2024 (view filing) | Feb 16-20 | 4 days | Scangos George ADirector | SSale | −27.8K | $10.23 | −$283.8K | −16.5%140.7K after | 2 lots10b5-1 |
| Feb 24, 2023 (view filing) | Feb 23-24 | 1 day | Scangos George APresident and CEO | SSale | −27.8K | $24.53 | −$680.8K | −14.1%168.5K after | 3 lots |
| Feb 21, 2023 (view filing) | Feb 17-21 | 4 days | Scangos George APresident and CEO | SSale | −27.8K | $27.23 | −$755.6K | −12.4%196.2K after | 3 lots |
| Feb 22, 2022 (view filing) | Feb 17-18 | 5 days | Scangos George APresident and CEO | SSale | −27.8K | $31.11 | −$863.4K | −19.7%113.0K after | 2 lots |